The Pharmaceuticals in Dosage Market Size Value Per Capita in Spain has shown a fluctuating trend from 2012 to 2022. Starting at $1.06K USD per capita in 2012, there was a slight decline until 2014. From 2015, the market experienced a more pronounced decrease, hitting $0.84813K in 2017. A minor recovery occurred in 2018 and 2019, followed by an uptick in 2020 to $0.95496K USD per capita. The value remained stable at around $1.0K in 2021 but dropped again in 2022 to $0.89918K USD per capita.
For 2023, the market stood at $0.89918K USD per capita. From 2022 to 2023, the value remained stable. Over the past five years, the CAGR indicates a slight negative growth.
Future trends to watch for include advancements in biotechnology, personalized medicine, and the impact of digital healthcare solutions. These factors could drive growth and innovation in the pharmaceutical market in Spain.
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 8 | 8 Israel | 990.06 | 2023 | View data | ||
| 9 | 9 United Kingdom | 969.43 | 2023 | View data | ||
| 10 | 10 Spain | 929.61 | 2023 | |||
| 11 | 11 Canada | 909.67 | 2023 | View data | ||
| 12 | 12 Sweden | 902.21 | 2023 | View data | ||
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
